ABSTRACT Unlabeled cholera toxin inhibits [125I] Cholera toxin can stimulate adenylate cyclase activity in thyroid plasma membranes. Its effect is not additive with that of thyrotropin, and cholera toxin can inhibit thyrotropin stimulation of the adenylate cyclase activity. NAD enhances cholera toxin stimulation of adenylate cyclase activity but has no enhancing effect on the stimulatory activity exhibited by thyrotropin.
ceed 40%, whereas unlabeled thyrotropin completely inhibits [125I~thyrotropin binding to these same membranes. Kinetic analyses of the binding data are compatible with the view that the cholera toxin decreases the number of receptor sites available to thyrotropin and that the mechanism by which the cholera toxin inhibits [250Ithyrotropin binding to these receptor sites involves both competitive and noncompetitive elements.
Cholera toxin can stimulate adenylate cyclase activity in thyroid plasma membranes. Its effect is not additive with that of thyrotropin, and cholera toxin can inhibit thyrotropin stimulation of the adenylate cyclase activity. NAD enhances cholera toxin stimulation of adenylate cyclase activity but has no enhancing effect on the stimulatory activity exhibited by thyrotropin.
The GM1 ganglioside [galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)galactosylglucosylceramideI in thyroid plasma membranes can be tritiated by treating membranes with galactose oxidase, followed by reduction with 3-H-labeled sodium borohydride. Cholera toxin at a concentration which yields maximal inhibition of thyrotropin binding to thyroid plasma membrane receptors prevents the labeling of GMI.
Fluorescence data indicate that the interaction between cholera toxin and GM1 results in a conformational change in the cholera toxin molecule. Analogous conformational alterations cannot be detected upon exposure of cholera toxin to 5-fold higher concentrations of N-acetylgalactosaminyl(N-acetylneuraminyl)-galactosylglucosylceramide (GMS) or N-acetylneuraminylgalactosylglucosylceramide (GM3).
In a previous report (1) we suggested that thyrotropin (TSH) and cholera toxin have an analogous mode of interaction with receptors on thyroid plasma membranes. We hypothesized that in both the case of TSH and cholera toxin, the ,B or B subunit interacts with specific cell surface receptors having gangliosides or ganglioside-like oligosaccharides as part of their core structures. This binding induces a conformational change in the hormone or toxin which results in translocation of an "active" a or A subunit within the cell membrane and adenylate cyclase activation. The evidence which led to this hypothesis can be summarized as follows. Thyrotropin and cholera toxin both bind 
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to gangliosides in vitro (1) (2) (3) (4) (5) . The binding of both molecules to the gangliosides is critically affected by the number and location of sialic acid residues on the carbohydrate portion of the ganglioside molecule (1) (2) (3) (4) (5) . The interaction of TSH and cholera toxin with gangliosides is associated with a change in their conformational states (1, 6) , which in the case of cholera toxin is believed to ultimately result in a dissociation of the toxin molecule (6) . Gangliosides which bind best to TSH in vitro, i.e., (7, 9) , the subunit believed to be associated with adenylate cyclase activation (5, 6 Gangliosides GM3, GM2, GM1, GD1a, GD1b, and GT1 were obtained as previously described (1, 15, 16) . Each ganglioside used in these experiments was at least 99% pure following rechromatography, visualization with resorcinol reagent, and densitometric analysis (16); gangliosides were quantitated from their sialic acid content using a micro-modification of the resorcinol method of Svennerholm (17) .
Gangliosides in bovine thyroid plasma membranes were labeled with tritium using the following procedure. Bovine thyroid plasma membranes (10 mg of membrane protein) were incubated in 0.01 M Tris-acetate at pH 6.0, for 30 min at 0°in the presence or absence of cholera toxin (9 ,M) and in a final volume of 3 ml. The membranes were sedimented by centrifugation at 10,000 X g at 0-4o, washed once with phosphatebuffered saline at pH 7.4, and resuspended to a final volume of 3 ml with phosphate-buffered saline at pH 7.4, which contained 40 units of galactose oxidase (Sigma Chemical Co.). The temperature was raised to 230 and the membranes were incubated for 2 hr with gentle shaking. The membranes were again centrifuged at 10,000 X g, washed with 0.05 M Tris-acetate at pH 7.8 which contained 0.05 M NaCl, and resuspended to a final volume of 3 ml in this same buffer. 3H-Labeled sodium 1 X 10 1 1 X 109 125I-TSH BOUND 1 X 10 -8 borohydride (specific activity 16 Ci/mmol), 3 mCi in a 200-AI volume of buffer, was added and the incubation at 23' was continued for 30 min with occasional shaking. Membranes were again sedimented by centrifugation at 10,000 X g and washed three times with cold 0.02 M Tris-acetate at pH 6.0. Gangliosides were extracted from the tritiated bovine thyroid membranes and purified by the method of Yu and Ledeen (18) , separated by thin-layer chromatography, radioscanned, and visualized with resorcinol reagent, as previously described (1, 16) .
Fluorescence measurements of cholera toxin solutions were carried out as previously described for TSH solutions (1), with the following exceptions: cholera toxin concentrations are based on colorimetric protein analyses (19) using bovine serum albumin as the standard; N-acetyltryptophan-NH2 solutions were used to monitor the stability of the instrument.
Adenylate cyclase assays were performed using the conditions of Rodbell and Krishna (20) as modified by Wolff and Jones (21) . Cyclic AMP was measured using a binding protein assay (22) . Thyroid plasma membranes for these experiments were prepared in 0.25 M sucrose, 1 mM EDTA, and 0.1% mercaptoethanol to enhance stability of the adenylate cyclase (21, 23 (1) .
An evaluation of the kinetics of this inhibition using a Scatchard analysis (24, 25) Fig. 1, 0 Fig. 2A , but using Lineweaver-Burk plotting techniques (26 (Fig. 1) . The inset is a blowup of the extrapolated lines as they cross the origin; the data are plotted by a computer which calculated the best fit lines, using a linear least squares fitting procedure. "C.T." in the inset represents cholera toxin. Assay conditions were the same as Figs. 1 (----) or absence of a 7 MM concentration of GM,. The cholera toxin concentration was 0.15 MM in this experiment and in the data depicted in the inset, where the GM1 effect on the emission of cholera toxin at 330 nm was compared to the effects of GM2 and GM3. Excitation was at 282 nm; the sample volume was 1.3 ml. A mixed ganglioside preparation containing 12% GM1, 16% GD1b, 47% GD1a, and 26% GT1 had the exact same effect as 7 MM GM,, suggesting that GD1b, GD1a, and Gri, like GM3 and GM2, have no significant effect on the spectra. In the inset, "C.T." stands for cholera toxin.
crease or decrease in the number of receptor sites available to bind TSH at concentrations of cholera toxin which enhance or inhibit binding, respectively ( Fig. 2A) . No significant alteration in the affinity of the sites for TSH is detectable in these analyses. A kinetic evaluation (Fig. 2B ) which adapts Lineweaver-Burk plotting techniques (26) indicates that the mechanism by which the cholera toxin displaces [1251]TSH from the receptor sites appears to be "mixed," i.e., has both a competitive and noncompetitive element (27) .
The Influence of Gangliosides on the Structure of Cholera Toxin. If GM1 is a structural component of the membrane which can interact with both TSH and cholera toxin, and if the mode of action of TSH and cholera toxin is similar, GM1 should induce in cholera toxin a conformational alteration which is both analogous to that imposed upon TSH and can be detectable by physical techniques such as fluorescence spectroscopy. The fluorescence emission spectrum of cholera toxin (Fig. 3) in 0.02 M Tris-acetate at pH 7 shows a maximum centered at 342 nm which is typical of proteins containing tryptophan (28) . Upon addition of GM1 (7 ,uM) , the peak emission is shifted to 330 nm. The 12-nm "blue shift" reflects a substantial decrease of the polarity of the indole chromophore environment which is likely to result from a conformational change of the protein. As the concentration of GM1 is increased, there is no further change in the emission maximum, although the relative intensity at 330 nm increases (Fig. 3 inset) . The effect of GM1 on the conformation of cholera toxin appears to be specific; thus, the gangliosides GM2 and GM3 at equivalent or up to 5-fold higher concentrations have no effect on (29) . In accord with his results, Fig. 4 (A) Tritium incorporation into the gangliosides of thyroid plasma membranes after exposure to galactose oxidase and subsequent reduction by 3H-labeled sodium borohydride. The gangliosides were subjected to thin-layer chromatography (picture), and the plates were scanned using a Vanguard radioscanning instrument (graph). Simultaneous chromatography of authentic GM1, GT1, GD1b, GM3, and GM2 allow the definition of the peaks of radioactivity. (B) Tritium incorporation into the gangliosides of thyroid plasma membranes preincubated with cholera toxin prior to galactose oxidase exposure and 3H-labeled sodium borohydride reduction. The concentration of cholera toxin during the preincubation period was sufficient to give maximal (40%) inhibition of [1251]TSH binding (Fig. 1) . Total radioactivity applied to the plates in (A) and (B), respectively, was 176,000 and 104,000 counts per min. The radioscanning sensitivity in (A) and (B) is identical.
should have tritium incorporated into ganglioside residues if these are available to the enzyme. As seen in Fig. 5 (top) , the major labeled ganglioside is GM1 when gangliosides are extracted from these membranes, chromatographed, and evaluated for their tritium content. In contrast, Fig. 5 (bottom) shows that the GM1 residues are not labeled with tritium if the thyroid membranes are preincubated with cholera toxin prior to galactose oxidase exposure and [3H]borohydride reduction. In addition, pretreatment with cholera toxin causes an enhancement of the labeling of other glycolipids contained in the membrane (Fig. 5, bottom) , and there is no labeling of GM1 in the absence of galactose oxidase (data not shown). MuM, sufficient to yield no significant net inhibition or enhancement; and by unlabeled cholera toxin plus an amount of unlabeled TSH sufficient to cause only 20% inhibition. As can be seen (Fig. 6A) , prior exposure of the membranes to a low concentration of TSH totally abolishes the enhancement effect of cholera toxin on [125I]TSH binding (Figs. 1 or 6B) . Similarly (Fig. 6B) , prior exposure of the membranes to 0.6 MM cholera toxin results in an increased ability of unlabeled TSH to inhibit binding. Thus, whereas 0.1 MAM TSH yields an inhibition of 15% when present alone, 0.1 MiM TSH results in a 45% inhibition in the presence of a concentration of cholera toxin which alone has no net effect on [l25I]TSH binding.
DISCUSSION
In our previous report, we showed that the efficacy by which gangliosides inhibited the interaction of TSH with thyroid plasma membrane receptors was GD1b > GT1 > GM1 and we suggested all three gangliosides could be elements or analogs of the TSH receptor, since these gangliosides coexist on thyroid plasma membranes. In the present report, we show that cholera toxin interacts with GM1 residues on thyroid plasma membranes, i.e., at 9 MiM cholera toxin, GM1 is completely protected from galactose oxidase attack (Fig. 5) (Fig. 6B) . These results could be accounted for by the following schema: TSH binds preferentially to receptor sites composed of GD1b or GT1 residues or their glycoprotein analogs, whereas cholera toxin binds preferentially to GM1 or GM1-like receptors. Reactivity at low concentrations of cholera toxin with GM1 results in a perturbation of the membrane which makes the GD1b or GT1 sites more accessible to TSH in the medium. The toxin thus behaves as a positively cooperative ligand, i.e., it increases the availability of the receptors for the hormone. The implication of these data and this schema is that ganglioside or ganglioside-like receptors on thyroid plasma membranes do not interact with TSH in an independent fashion but rather in a cooperative mode. Further, the cooperativity may become negative under normal circumstances, i.e., faced with high concentrations of TSH interacting with the GM1 sites, the membrane perturbation can alter the environment of GD1b-or GTI-like sites already containing TSH and thereby enhance dissociation from these previously. occupied sites. Such a phenomenon could be the basis for the curvilinear Scatchard plots and "negative cooperativity" among TSH receptors which we previously described (13) .
By its interaction with the GM1 ganglioside, cholera toxin may be subverting a normal mechanism by which TSH interacts with the thyroid plasma membrane and transfers its message to the cell machinery. The present data, which show that cholera toxin undergoes a conformational transition upon interacting with GM1, are both in accord with this hypothesis and suggest that this conformational transition may well be a necessary prelude to the formation of an "active" A subunit of cholera toxin capable of interacting with components within the cell membrane.
It is in this last respect that the adenylate cyclase data presented are pertinent. Cholera toxin stimulation of adenylate cyclase activity in thyroid plasma membranes requires NAD; TSH stimulation does not. A divergent molecular mechanism for cyclase activation must thus be anticipated, despite the analogies at the receptor level and at the level of effector penetration or translocation within the membrane. It is pertinent at this point to recall the molecular mechanism by which diphtheria toxin subverts the normal protein synthetic machinery of the cell, i.e., through the formation of an abnormal covalent linkage of NAD to elongation factor-2 (32). These results thus enhance the importance of the efforts by Gill (29) who has already initiated a search for a membrane component which accepts NAD in covalent linkage upon the interaction of cholera toxin with the membrane.
A final point should be made concerning the data of Table  1 . The ability of gangliosides to inhibit both the basal-and fluoride-stimulated adenylate cyclase activity has at this time no definitive explanation. These results are not caused by the gangliosides interfering with the cyclic AMP binding protein assay. A similar inhibition of basal adenylate cyclase activity by gangliosides has been observed in cultured mouse cells (33) . Since exogenous gangliosides can be integrated into intact cells (34) and membranes (2), integration of gangliosides into the fluid phase of the membrane may perturb the membranebound adenylate cyclase activity.
